SMTL ID : 8ucc.2 (1 other biounit)

IRAK4 in complex with compound 20

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x WFQ: (4S)-2-[(1R,4s)-1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl]-N-[(8S)-6-methylpyrazolo[1,5-a]pyrimidin-3-yl]-7-[(propan-2-yl)oxy]imidazo[1,2-a]pyrimidine-6-carboxamide

WFQ.1: 15 residues within 4Å: Chain A: M.39, G.40, V.47, A.58, Y.109, V.110, Y.111, M.112, P.113, G.115, S.116, R.120, L.165, S.175, D.176 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.47, A:Y.109 Hydrogen bonds: A:M.112 Water bridges: A:V.110, A:S.116, A:R.120

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Evans, R. et al., The Discovery of 7-Isopropoxy-2-(1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)- N -(6-methylpyrazolo[1,5- a ]pyrimidin-3-yl)imidazo[1,2- a ]pyrimidine-6-carboxamide (BIO-7488), a Potent, Selective, and CNS-Penetrant IRAK4 Inhibitor for the Treatment of Ischemic Stroke. J.Med.Chem. (2024)

Release Date

2024-06-26

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence